Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Astellas Diabetes Drug Shown to Be Effective in Phase III Study

Sept. 16 (Bloomberg) -- Astellas Pharma Inc. said its diabetes treatment ipragliflozin was shown to be effective and safe in a Phase III clinical trial in Japan. The Japanese drugmaker made the comment today in a statement on its website.

Link to Company News:{4503 JP <Equity> CN <GO>}

To contact the reporter on this story: Go Onomitsu in Tokyo at gonomitsu@bloomberg.net

To contact the editor responsible for this story: Kyung Bok Cho at kcho7@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.